17
Participants
Start Date
August 4, 2014
Primary Completion Date
December 11, 2017
Study Completion Date
May 8, 2018
2.4 mg/kg α-TEA
Patients receive oral α-TEA 2.4 mg/kg daily for the first 14 days of a 28 day cycle.
4.8 mg/kg α-TEA
Patients will receive oral α-TEA 4.8 mg/kg daily for the first 14 days of a 28 day cycle.
8.0 mg/kg α-TEA
Patients will receive oral α-TEA 8.0 mg/kg daily for the first 14 days of a 28 day cycle.
9.6 mg/kg α-TEA
Patients will receive oral α-TEA 9.6 mg/kg daily for the first 14 days of a 28 day cycle.
12 mg/kg α-TEA
Patients will receive oral α-TEA 12 mg/kg daily for the first 14 days of a 28 day cycle.
16.8 mg/kg α-TEA
Patients will receive oral α-TEA 16.8 mg/kg daily for the first 14 days of a 28 day cycle.
19.2 mg/kg α-TEA
Patients will receive oral α-TEA 19.2 mg/kg daily for the first 14 days of a 28 day cycle.
22.3 mg/kg α-TEA
Patients will receive oral α-TEA 22.3 mg/kg daily for the first 14 days of a 28 day cycle.
26.8 mg/kg α-TEA
Patients will receive oral α-TEA 26.8 mg/kg daily for the first 14 days of a 28 day cycle.
Providence Oncology & Hematology Care Clinic- Southeast, Clackamas
Providence Oncology & Hematology Care Clinic- Willamette Falls, Oregon City
Providence Oncology & Hematoloty Care Clinic- Newberg, Newberg
Providence Oncology & Hematology Care Clinic- Eastside, Portland
Providence Oncology & Hematology Care Clinic- Westside, Portland
Providence Health & Services
OTHER